Delivery Order SPE2DB20D1110-SPE2DB24FJ94D
Award Date 2/12/24
Potential Completion Date 2/13/24
Potential Value $6.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $7,311.50 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of XARELTO 20 MG TABLET 90S. This delivery order falls under an indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of XARELTO 20 MG TABLET 90S. The contract has a potential value of $4,941.16 and a completion date of February 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 90-count tablets of the pharmaceutical product XARELTO 20 mg. The contract has a ceiling value of $11,759.26 and a period of performance through March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to...
- The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract valued at $106,692.20 to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of XARELTO 20 MG TABLET 90S, a pharmaceutical product, with an ultimate completion date of August 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to supply XARELTO 20 MG TABLET 90S to support military treatment programs and facilities. The contract has a potential value of $15,433.55 and a period of performance through March 7, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,193.75 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4564159579 XARELTO 20 MG TABLET 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued up to $999,999,999.00 and with a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of $8,069.99 worth of XARELTO 20 MG TABLET 90S. This contract, which has a completion date of February 29, 2024, is not set-aside and was awarded on February 28, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor, delivering pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a $14,019.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division to supply XARELTO 20 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of critical pharmaceutical and medical supplies. As a major pharmaceutical distributor,...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Xarelto 20 mg tablets. The contract has a potential value of $3,315.36 and a completion date of February 29, 2024. This award is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563982009 XARELTO 20 MG TABLET 90S. The $11,738.39 contract has a period of performance through March 18, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp serves as a prime contractor providing a range of pharmaceutical products and medical supplies to U.S. government agencies, primarily...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB24FJ94DDelivery Order
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XARELTO 20 MG TABLET 90S. The contract has a potential value of $6,695.04 and a completion date of February 13, 2024. This award is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Generated 5/13/24, 9:04 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 2/12/24 |